Lobbying Filing Details
Total Spending
$80,000
Activities
5
Lobbyists
4
Gov't Entities
11
Filing Information
- Filing UUID:
665ad769-2acd-4482-9978-3c681774b4fe- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2026 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 20, 2026 at 6:54 PM
- Income:
- $80,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Isabella Quinn
Registrant
WILLIAMS AND JENSEN, PLLC
Lobbying Law Firm
Washington, District of ColumbiaClient
BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.)
Healthcare/Pharmaceuticals
Massachusetts, United States of AmericaLobbying Activities (5)
Activity 1
Health IssuesMonitor progress of next Prescription Drug User Fee Reauthorization, issues relating to US and international manufacturing, oncology issues, FDA reorganization and programs, 340B, monitoring efforts around direct-to-consumer policies.
Lobbyists (3)
- SUSAN HIRSCHMANN
- MR. MATTHEW B HOEKSTRA
- JEANNE HAGGERTY
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
ManufacturingMonitoring efforts to onshore and build US pharmaceutical manufacturing capacity.
Lobbyists (3)
- SUSAN HIRSCHMANN
- MR. MATTHEW B HOEKSTRA
- JEANNE HAGGERTY
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
Medicare/MedicaidIssues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing), access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.
Lobbyists (3)
- SUSAN HIRSCHMANN
- MR. MATTHEW B HOEKSTRA
- JEANNE HAGGERTY
Government Entities (3)
- SENATE
- HOUSE OF REPRESENTATIVES
- Centers For Medicare and Medicaid Services (CMS)
Activity 4
PharmacyH.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.
Lobbyists (3)
- SUSAN HIRSCHMANN
- MR. MATTHEW B HOEKSTRA
- JEANNE HAGGERTY
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 5
Trade (domestic/foreign)Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.
Lobbyists (4)
- SUSAN HIRSCHMANN
- MR. CHRISTOPHER W HATCHER
- MR. MATTHEW B HOEKSTRA
- JEANNE HAGGERTY
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES